(完整版)药理学名词解释

尸I--sss*HSSSON»替奈9(ckugaction)-»替迓31$3苕1^9、S3JH。w*stsst冒(pharmaco一ogica-effect)-»替奈afl30u$JgEF3^9o'@»替奈aflsfflrw。4,吻3££(adverseFeaaion)-R^afl3tnDsMI>H:、»帖»43|»>|^1£18曲31^0<帖»瞽>|6,(toxicreaction)：、8"(withdr-awa-reaction)-»渕<9253|9|^^3»3輕、xls;回、5K»3a凹S^K9"(idiosyncrati:eaction)-J>sswsalal>A^牌ls»替SJSSSIMK、»10"灣lll・»s^s(dose,effectre-ationship)-11"S^BK(dosfdfectcurve)-9»冒3£^翳膿前"ats灣・SK!5S^£^»膿前帝12,ngEF(gddedepi)：f3SWSSM31、sa§ESS33«13,Gi烦EF(quanta一responseo『a_lo7noneresponse)：stasK冒^Misvis替灣KKSUysss薪惡芋⑥永爭|>/筛端撚瀛眾坎寻令14"fll3TI^r勇lffii(aA1)、dlr瞬瘦»#ag帝凹mM1»3S^S3S»24’mi(antagonist)••fiss・^>1$}£赫»(competitiveantagonist)：鑫血贈3J3t^^BalMl1$、^@血»凹»s、ssm、sssa..ss(PA2)：^l»si£3、«2smissfisn^_sst、msMnslssPAW、S3SH9K27"帯^^1£}£赫»(noncompetitiveantagonist)：dlr贈蓉3t#afl3、凹ot3J3t9ttat±dlrNmB»s_£、2尸MH$FSS(『eceptordesensitN'ation)-mJKasral—尊贍sbKan、s^»998s贍sb»3w^29,)ffl$Fs8(『eceptoFhypersensitization)-凹HMl$F3t3J3t$t«n/筛端撚瀛眾坎寻令39"wii-bioabaifirbEty)：S1^B»常B4I—屢・s3t替Dnalls粘吕a斟$»替Sssssn-40"—»谨鄭蓉廿惟(first6le『e_iminationUnetics)-A4*a3tsm1BBa画aaig鄭sstsml^曹熠、S!§3al3SN^SS^SM^、ss»n»、§3^13»t、ss»n_£3、S3al3SS@P4尸^^谨鄭蓉廿惟(S36ise_iminationkinetics)：替mssluls^sis^aigs、BP^IBss^ni、S3al3SN^42,fssH^、cl)：^siswmslsnssi、—Sias43"ws^mla站(appar-entvocmeofdistribution、Vd)-llKI01Mas^a3ls^ai££lwjDn、^an33SSM»m^a^a3SHSBal.44,aes(incompatibEty)：smsiEMSSisssmi46"(dependence)-msswii、48"9»1s»lffi1s(acuteto一eFance'tachyphy一axis)-attssl替5aasal®J>Jl今灣BJSS凹®s^lffKMHS。49,3JXBM11S(crosstomrance)：谊—尊3tsp>ffs!gg、mEFaflall)K3tsHstB»TI>ffs!Ml1s。50"Jg!Msn»(『ebound『eaction)：木爲画AEaflMIIKatsBIT^S、1RS卅冊陰X、、sssns—5尸fsHffi吟aE/m3®R(withdi-awa一一abstinencesyndrome"Jgwlaflst、{ESIsuwwilHSJi52"93|奈9(synergism)：»翻^5ssaflDns»JS±4l翻stIBalsalsa。53"m赫奈9(antagonism)：54"ss(drugabuse)：55"弐SS5瞽(antibacteria-drugs)-、94l»sa^?il99i31£弐府潇(antibiotics)••議府替雪去翠替・■嘗・islessMSSSO吉SB(bacEiostaticckugs)：、SBss,SSH.58,(baft船2:da-dnlgMr・sllMM猶fis^mntt濟59"^Btt(antibacterialspectrum)：srBst替s^S^Kfflo60"^惟诱通(chemotherapy)-迓aw^SHs、回BR議Iff芦Mw虽、EnSNa苗3H7SG^3»61"U0?1BS(chemotherapeutic:index・CI)：MiwMb惟ISJ?3t替a!t»1sl!frs^1s3»1s、KluSIS*IBLD50memo器9LD®dfr395N62,(bacteria-resistance)：、ssiass63,HK^(supe=.ns'ctkms)：IExA口囲ap1DSH番沏lalsm專屬。床8口H凰§3—mBIBSS-64"赫Hsn違B(postantibioticeffect、PAE)-MICS^MI赫HstDn、鄭讯、ssss、ssn65"赫HMIS(antibatena-activity"^Bst瞽君xsl^^slBsiEtf。66"BOPH碧n(minima-inhibitoryconcentration'MIC)m肆Hso^*、stsfl^opxffi^67"s4E»HMn(minima-bacterkida-concentration'MBC)m$F9Hjt^*'»替fl^ll$IKxlssassn-68"MS01S(tr-appingmechanism)-B3»s»凹dlrMl£»»?Nm&^s>ff!Ms^g血、1£3t69"苗33»皿黑郸1£»替(ce一一cydenonspecificagents'CCNSA"ng®xl^^s@mBI*3a3—wsffi00Sisi--n70"苗3JVSS郸1£»替(ce=cydespecificagents'CCSA)-6^s@ma3Mle3ams哥迓Q0SI^S3s>flsSM番芦71"^KHSIS(muEdnlgresistance、MDRrJMBSjsasBlfwjtffiISJWBslDn、lt>ff759w蓉ffirw训画、si$3Msl£»3sp72,asks字agsa琳(ad『ena_me『eveg二：、wt73"(『evegusebependence)：胀寻«*3、»瞽£:^3奈(9倉8383奈9吻9la、a^saa、S3H«潇湘行内部资料by凌霄焰鹰版权所有774、调节痉挛(spasmsofaccomodation):动眼神经兴奋时或毛果芸香碱作用后睫状体环状肌向瞳孔中心方向收缩，造成悬韧带放松，晶状体由于本身弹性变凸，屈光度增加，此时只适合于视近物，而难以看清远物。这种作用叫调节痉挛。75、调节麻痹(paralysisofaccomodation):阿托品能使睫状肌松弛而退向外缘，使悬韧带拉紧，晶状体变为扁平，其折光度减低，只适合看远物，而不能将近物清晰地成像于视网膜上，造成视近物模糊不清，此即为调节麻痹。Drug，drugaction，pharmacologicaleffect，adversereaction，sideraction，toxicreaction，residualeffect，withdrawalreaction，idiosyncraticreaction，dose-effectrelationship，dose-effectcurve，gradedresponse，quantalresponseorall-or-noneresponse，minimaleffectivedose，maximaleffect，Emax，potency，medianeffectivedose，ED50，medianlethaodose，LD50，therapeuticindex，TI，receptor，intrinsicactivity，agonist，partialagonist，antagonist，competitiveantagonist，pA2，noncompetitiveantagonist，receptordesensitization，receptorhypersensitization，up-regulation，down-regulation，iontrapping，absorption，firstpasselimination/effect/metabolism，distribution，enterohepaticcycle，halflife，areaundercurve，AUC，bioabailability，first-ordereliminationkinetics，zero-ordereliminationkinetics，clearance，CL，apparentvolumeofdistribution，Vd，incompatibility，placebo，dependence，tolerance，acutetolerance/tachyphylaxis，crosstolerance，reboundreaction，withdrawal／abstinencesyndrome，synergism，antagonism，drugabuse，antibacterialdrugs，antibiotics，bacteriostaticdrugs，bactericidaldrugs，antibacterialspectrum，chemotherapy，chemotherapeuticindex，CI，bacterialresistance，superinfections，postantibioticeffect，PAE，antibaterialactivity，minimalinhibitoryconcentration，MIC，minimalbactericidalconcentration，MBC，trappingmechanism，cell薪惡芋⑥永爭|>/筛端撚瀛眾坎寻令cydenonspecificagents、CCNSA、ce一一cydespecificagents、CCSA、muEdsgresistance、MDR、adrena-inereversa-二everseuse・dependence・spasmsofaccomodation、para一ysisofaccomodation尸sis-cho-inel-giccrisis)：isssMS・・s2’3-&l^J£a(1£(intrinsicsympathomimeticactivity、ISA)：dtlfiBaskISMlesISBiisIIJTBMHffi$F9H^5£(extr-apyr-amida-reaction)：^»±slJaasn3»、田4JH3»KS371H4’a^si(aspirinasthma)：ii9i99s§in^sss、dlrpg、褊pgssi、剖田»號3LTSwwennISIS、«專Jlr@sw謝常輾s。s»弼雷(Rey电ssyndFonwr建LmialM專曽薔“具m"s*99SS3、、iws$Btf»ss、SI-当断(reentry)••iM»l9£^ss£$sss・御理第ssssssv.Sissis^7"Dn鄭s(aftei-depo一arization)：Msw^-H、、ssxs、常&昴XbfllDn雷蓉證Dn雷。8"fllDn鄭s(ea『_yafterdepo一arization、EAD)：«>ffm^l»nR±s3anl®R、xKlffm2"3ans、APDistss^a曲條9"asDn鄭s(de一ayedafte『depo一arizationbAD)：B9s3sil»«a«>ffm3^(iB4^l»魁10"^ssJg^nindlonism)：田4|木3画冉9IWSDT、哥au-i&3^ui"洋事"mm"Bffii"臨&"一尸(permissiveaction)-常s»星。12"^mffiDkSE(graysyndromesfllllJunili^JLsmRSttsiiR13"ttmJ^(her-h2.me;eation)：G・2F3lsi£$F«cho-inergiccrisisIntrinsicsympathomimeticactivityJSA'extrapyramida-reactionbspirinasthma、Reyfltssyndrome、『eentry、afte『depo一arization、earlyafte『depo一arization、EAD、de-ayedafterdepo一a『N'atio3DAD、cinchonism、permissiveaftherheimerreation